Connect your AI

D-Wave Quantum QBTS Deferred Finance Costs Noncurrent Net

Deferred Finance Costs Noncurrent Net at other companies

Clearwater AnalyticsCWAN

$3.27M+1,023%

Essential UtilitiesWTRG

$53.81M+15.0%

Jazz PharmaceuticalsJAZZ

$7.1M-21.1%

RayonierRYN

$4K—

TG TherapeuticsTGTX

$0—

Match GroupMTCH

$100K—

Other financials

Income statement

Revenue$2.9M-80.9%

Gross profit$1.8M-86.9%

Operating income-$54.7M-385%

Net income-$18.4M-239%

EPS (diluted)-$0.05-150%

Balance sheet

Cash & equivalents$338.2M+11.1%

Total debt$46.7M+22.5%

Total equity$1.1B+442%

Total assets$1.2B+268%

Cash flow

Operating cash flow-$45.0M-133%

CapEx$1.1M+147%

Free cash flow-$46.0M-134%

Valuation

Market cap$9.15B+141%

Enterprise value$8.85B+159%

P/S735×+557×

Profitability

Gross margin66.3%-17.0pp

Operating margin-1,155.6%-1,938pp

Net margin-2,957.2%-4,019pp

FCF margin-821%-1,451pp

Returns & leverage

Return on equity-55.3%—

Debt / equity0×-0.1×

Current ratio21.4×+0.7×

Where this comes from

Reported directly by D-Wave Quantum in its filing.

Tagged under the XBRL concept us-gaap:DeferredFinanceCostsNoncurrentNet.

The official record: D-Wave Quantum’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about D-Wave Quantum's deferred finance costs noncurrent net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is D-Wave Quantum's deferred finance costs noncurrent net?: D-Wave Quantum (QBTS) reported deferred finance costs noncurrent net of $742K in Q1 2026.